Allen Operations’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Allen Operations’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,437	Closed	-$134K	–	39
2023 Q3	$134K	Hold	25,437	–	–	0.03%	36
2023 Q2	$179K	Hold	25,437	–	–	0.04%	36
2023 Q1	$242K	Hold	25,437	–	–	0.06%	35
2022 Q4	$155K	Hold	25,437	–	–	0.04%	38
2022 Q3	$353K	Hold	25,437	–	–	0.09%	37
2022 Q2	$1.02M	Hold	25,437	–	–	0.26%	29
2022 Q1	$2.68M	Hold	25,437	–	–	0.47%	23
2021 Q4	$2.93M	Hold	25,437	–	–	0.41%	24
2021 Q3	$9.63M	Hold	25,437	–	–	1.49%	19
2021 Q2	$10.4M	Hold	25,437	–	–	1.78%	16
2021 Q1	$12.1M	Buy	+25,437	New	+$13.8M	2.47%	15

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allen Operations's NEXI Position: Q4 2023 in Review

Allen Operations sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 25,437 shares — an estimated $134K sold.

Allen Operations first reported a position in NEXI in Q1 2021 and held it in 11 quarters. The position peaked at $12.1M in Q1 2021. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Allen Operations reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Allen Operations sold 25,437 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $134K.
Allen Operations first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
Allen Operations's NexImmune, Inc. Common Stock position peaked at $12.1M in Q1 2021.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Allen Operations's 13F filing for Q4 2023, filed 14 Feb 2024.